Sign in with Google
bullish
Hugel: Botulinum Injects Sales from Exports
348 Views10 Aug 2017 05:21
Strong sales momentum, low price volatility versus the Korean market,and improving asset turnover relative to its sector
In April, Hugel signed a...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
A. Stotz Investment Research
Quantamental Investing to beat Benchmarks
Price Chart(Sign Up to Access)
- Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)19 Apr 2022
- The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?14 Aug 2021
- Hugel Placement: A 5.2% Block Deal Sale29 Jun 2020
- Hugel: Botulinum Injects Sales from Exports10 Aug 2017
x